W E Mercer

13.8k total citations · 2 hit papers
53 papers, 12.0k citations indexed

About

W E Mercer is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, W E Mercer has authored 53 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 25 papers in Oncology and 13 papers in Biotechnology. Recurrent topics in W E Mercer's work include Cancer-related Molecular Pathways (23 papers), Cancer Research and Treatments (11 papers) and Virus-based gene therapy research (9 papers). W E Mercer is often cited by papers focused on Cancer-related Molecular Pathways (23 papers), Cancer Research and Treatments (11 papers) and Virus-based gene therapy research (9 papers). W E Mercer collaborates with scholars based in United States, Poland and Italy. W E Mercer's co-authors include David Pei‐Cheng Lin, Victor E. Velculescu, Daniel B. Levy, Bert Vogelstein, Ramon Parsons, Takashi Tokino, J.M. Trent, Wafik S. El‐Deiry, K W Kinzler and Renato Baserga and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

W E Mercer

53 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WAF1, a potential mediator of p53 tumor suppression

1993 7.2k citations Wafik S. El‐Deiry, Takashi Tokino et al. Cell profile →
Induction of WAF1/CIP1 by a p53-independent pathway.

1994 699 citations David Pei‐Cheng Lin, W E Mercer et al. profile →

Peers

Countries citing papers authored by W E Mercer

Since Specialization

Citations

This map shows the geographic impact of W E Mercer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W E Mercer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W E Mercer more than expected).

Fields of papers citing papers by W E Mercer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W E Mercer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W E Mercer. The network helps show where W E Mercer may publish in the future.

Co-authorship network of co-authors of W E Mercer

This figure shows the co-authorship network connecting the top 25 collaborators of W E Mercer. A scholar is included among the top collaborators of W E Mercer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W E Mercer. W E Mercer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Downregulation of Wip-1 phosphatase expression in MCF-7 breast cancer cells enhances doxorubicin-induced apoptosis through p53-mediated transcriptional activation of Bax 2009 ·Cancer Biology & Therapy ·(unknown), Xiaoshan Jiang, W E Mercer	26
2	A Novel MDMX Transcript Expressed in a Variety of Transformed Cell Lines Encodes a Truncated Protein with Potent p53 Repressive Activity 1999 ·Journal of Biological Chemistry ·Ravikumar Rallapalli, (unknown), Brian Cho, W E Mercer, David J. Hall	81
3	Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene. 1998 ·Journal of Clinical Investigation ·Cinzia Sevignani, Paweł Włodarski, (unknown), W E Mercer, (unknown), Renato V. Iozzo, Bruno Calabretta	32
4	Pathways of p53-Dependent Apoptosis 1997 ·Vitamins and hormones ·Luigi Grasso, W E Mercer	7
5	Immunohistochemical localization of p21WAF1/CIP1 in normal, hyperplastic, and neoplastic uterine tissues 1997 ·Human Pathology ·Juan Palazzo, W E Mercer, Albert J. Kovatich, (unknown)	46
6	Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner 1997 ·Proceedings of the National Academy of Sciences ·Michele Fiscella, Hongliang Zhang, Saijun Fan, Kazuyasu Sakaguchi, (unknown), W E Mercer, George F. Vande Woude, P M O'Connor, Ettore Appella	454
7	The role of p53, p21WAF1/C1P1, and bcl-2 in radioresistant colorectal carcinoma 1997 ·Human Pathology ·Juan Palazzo, (unknown), Luigi Grasso, (unknown), Cheryl A. Hanau, (unknown), W E Mercer	33
8	Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. 1994 ·Proceedings of the National Academy of Sciences ·David Pei‐Cheng Lin, Michele Fiscella, P M O'Connor, Joany Jackman, (unknown), Lu Luo, Arturo Sala, Salvatore Travali, Ettore Appella, W E Mercer	97
9	WAF1, a potential mediator of p53 tumor suppression breakdown → 1993 ·Cell ·Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu, Daniel B. Levy, Ramon Parsons, J.M. Trent, David Pei‐Cheng Lin, W E Mercer, K W Kinzler, Bert Vogelstein	7234
10	Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53 1992 ·Experimental Cell Research ·Jane R. Noble, Karen Willetts, W E Mercer, Roger R. Reddel	26
11	Cell Cycle Effects of Microinjected Antisense Oligodeoxynucleotides to p34^cdc2 Kinasea 1992 ·Annals of the New York Academy of Sciences ·W E Mercer, Stephen J. Ullrich, (unknown), David Pei‐Cheng Lin, Hansjüerg Alder	10
12	Effects of catecholamines on fetal rat cardiocytes in vitro 1989 ·American Journal of Anatomy ·Thomas A. Marino, (unknown), (unknown), W E Mercer	14
13	Growth factor regulated expression of poly(A)+ binding protein messenger RNA 1989 ·Experimental Cell Research ·W E Mercer, Dariusz Jaskulski, (unknown)	9
14	Growth-Related expression of a 72,000 molecular weight poly(A)+ mRNA binding protein 1988 ·Experimental Cell Research ·Stephen J. Ullrich, Ettore Appella, W E Mercer	7
15	Cell cycle analysis of human peripheral blood T lymphocytes in long-term culture 1987 ·Experimental Cell Research ·Leszek Kaczmarek, Bruno Calabretta, I. Bruce Elfenbein, W E Mercer	6
16	Production of transgenic mice following deoxyribonucleic acid microinjection and embryo freezing 1987 ·Theriogenology ·Robert M. Petters, B. H. Johnson, W E Mercer	2
17	TPA-induction of c-fos mRNA during the cell cycle of WI-38 human fibroblasts 1987 ·Biochemical and Biophysical Research Communications ·Bruno Calabretta, W E Mercer	6
18	Adenovirus Type 2 Activates Cell Cycle-Dependent Genes That Are a Subset of Those Activated by Serum 1985 ·Molecular and Cellular Biology ·(unknown), Renato Baserga, W E Mercer	26
19	Cell cycle re-entry of quiescent mammalian nuclei following heterokaryon formation 1980 ·Experimental Cell Research ·W E Mercer, Robert Schlegel	13
20	Characterization of the DNA from four heliothis nuclear polyhedrosis virus isolates 1978 ·Virology ·William J. McCarthy, W E Mercer, Thomas F. Murphy	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact